These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36509738)

  • 1. Regulation of bone homeostasis by MERTK and TYRO3.
    Engelmann J; Zarrer J; Gensch V; Riecken K; Berenbrok N; Luu TV; Beitzen-Heineke A; Vargas-Delgado ME; Pantel K; Bokemeyer C; Bhamidipati S; Darwish IS; Masuda E; Burstyn-Cohen T; Alberto EJ; Ghosh S; Rothlin C; Hesse E; Taipaleenmäki H; Ben-Batalla I; Loges S
    Nat Commun; 2022 Dec; 13(1):7689. PubMed ID: 36509738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyro3, Axl, and Mertk receptors differentially participate in platelet activation and thrombus formation.
    Zhou J; Yang A; Wang Y; Chen F; Zhao Z; Davra V; Suzuki-Inoue K; Ozaki Y; Birge RB; Lu Q; Wu Y
    Cell Commun Signal; 2018 Dec; 16(1):98. PubMed ID: 30541554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor tyrosine kinases Tyro3, Axl, and Mertk differentially contribute to antibody-induced arthritis.
    Gao L; He C; Yang A; Zhou H; Lu Q; Birge RB; Wu Y
    Cell Commun Signal; 2023 Aug; 21(1):195. PubMed ID: 37537628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma.
    Holtzhausen A; Harris W; Ubil E; Hunter DM; Zhao J; Zhang Y; Zhang D; Liu Q; Wang X; Graham DK; Frye SV; Earp HS
    Cancer Immunol Res; 2019 Oct; 7(10):1672-1686. PubMed ID: 31451482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyro3/Axl/Mertk-deficient mice develop bone marrow edema which is an early pathological marker in rheumatoid arthritis.
    Waterborg CEJ; Koenders MI; van Lent PLEM; van der Kraan PM; van de Loo FAJ
    PLoS One; 2018; 13(10):e0205902. PubMed ID: 30335822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted degradation of MERTK and other TAM receptor paralogs by heterobifunctional targeted protein degraders.
    Gadiyar V; Patel G; Chen J; Vigil D; Ji N; Campbell V; Sharma K; Shi Y; Weiss MM; Birge RB; Davra V
    Front Immunol; 2023; 14():1135373. PubMed ID: 37545504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-intrinsic regulation of murine epidermal Langerhans cells by protein S.
    Tabib Y; Jaber NS; Nassar M; Capucha T; Mizraji G; Nir T; Koren N; Aizenbud I; Maimon A; Eli-Berchoer L; Wilensky A; Burstyn-Cohen T; Hovav AH
    Proc Natl Acad Sci U S A; 2018 Jun; 115(25):E5736-E5745. PubMed ID: 29871951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells.
    Seitz HM; Camenisch TD; Lemke G; Earp HS; Matsushima GK
    J Immunol; 2007 May; 178(9):5635-42. PubMed ID: 17442946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer.
    Dufour F; Silina L; Neyret-Kahn H; Moreno-Vega A; Krucker C; Karboul N; Dorland-Galliot M; Maillé P; Chapeaublanc E; Allory Y; Stransky N; Haegel H; Menguy T; Duong V; Radvanyi F; Bernard-Pierrot I
    Br J Cancer; 2019 Mar; 120(5):555-564. PubMed ID: 30765874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of lung homeostasis and silicosis by the TAM receptors MerTk and Axl.
    Guimarães-Pinto K; Leandro M; Corrêa A; Maia EP; Rodrigues L; da Costa ALA; Rafael Machado Ferreira J; Claudio-Etienne E; Siebenlist U; He J; Rigoni TDS; Ferreira TPT; Jannini-Sa YAP; Matos-Guedes HL; Costa-da-Silva AC; Lopes MF; Silva PMR; Kelsall BL; Filardy AA
    Front Immunol; 2024; 15():1380628. PubMed ID: 38774866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular Dormancy.
    Cackowski FC; Eber MR; Rhee J; Decker AM; Yumoto K; Berry JE; Lee E; Shiozawa Y; Jung Y; Aguirre-Ghiso JA; Taichman RS
    J Cell Biochem; 2017 Apr; 118(4):891-902. PubMed ID: 27753136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Mertk Signaling Enhances Bone Healing after Tooth Extraction.
    Decker AM; Matsumoto M; Decker JT; Roh A; Inohara N; Sugai J; Martin K; Taichman R; Kaigler D; Shea LD; Núñez G
    J Dent Res; 2023 Sep; 102(10):1131-1140. PubMed ID: 37350025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAM receptors Tyro3 and Mer as novel targets in colorectal cancer.
    Schmitz R; Valls AF; Yerbes R; von Richter S; Kahlert C; Loges S; Weitz J; Schneider M; Ruiz de Almodovar C; Ulrich A; Schmidt T
    Oncotarget; 2016 Aug; 7(35):56355-56370. PubMed ID: 27486820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin-3 Stimulates Tyro3 Receptor Tyrosine Kinase and Erk Signalling, Cell Survival and Migration in Human Cancer Cells.
    Al Kafri N; Hafizi S
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32664510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic targeting of the functionally elusive TAM receptor family.
    Miao YR; Rankin EB; Giaccia AJ
    Nat Rev Drug Discov; 2024 Mar; 23(3):201-217. PubMed ID: 38092952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting.
    Peeters MJW; Rahbech A; Thor Straten P
    Cancer Immunol Immunother; 2020 Feb; 69(2):237-244. PubMed ID: 31664482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonistic Coevolution of MER Tyrosine Kinase Expression and Function.
    Evans AL; Blackburn JWD; Taruc K; Kipp A; Dirk BS; Hunt NR; Barr SD; Dikeakos JD; Heit B
    Mol Biol Evol; 2017 Jul; 34(7):1613-1628. PubMed ID: 28369510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment.
    Myers KV; Amend SR; Pienta KJ
    Mol Cancer; 2019 May; 18(1):94. PubMed ID: 31088471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAM receptor signaling in development.
    Burstyn-Cohen T
    Int J Dev Biol; 2017; 61(3-4-5):215-224. PubMed ID: 28621419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tyro3 and CDK9 as biomarkers for drug resistance to breast cancer anti-PD-1 therapies].
    Zhang JF; Liu T
    Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):651-656. PubMed ID: 37580269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.